Department of Neurology
Xuzhou, Jiangsu, China
Location status: Recruiting
NCT Number: NCT05098340
CRAST is to analyze the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Xuzhou, Jiangsu, China
Location status: Recruiting
Circular RNAs have been highlighted to be involved in the pathological process of ischemic stroke (IS). The purpose of this protocol will investigate the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke. Distinctive expression patterns of circRNA will be identified by individual quantitative real time polymerase chain reaction (qRT-PCR). A diagnostic or predictive model will be established using logistic regression. The panel of these altered circRNAs may be associated with acute IS and could serve as a novel diagnostic or predictive method.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Quantitative Real-time polymerase chain reaction of circular RNA (circRNA).
Time frame: 90 days
Differential expression pattern of circular RNA (circRNA) will be compared between AIS group and HC group, thus candidate circRNA will be verified as biomarkers for the detection and prognosis of AIS.
Time frame: 90 days
Dynamic changes of circRNA will be explored before and after endovascular therapy
Time frame: 30 days
Correlation of circRNA and stroke-associated infection will be explored in acute ischemic stroke.
Time frame: 7 days
Correlation of circRNA and inflammatory factors on admission will be explored in acute ischemic stroke.
Time frame: 90 days
The prognosis of AIS patients will be analyzed between differential expressed candidate circRNA after they have completed the systematic therapy.
Contact information is provided by the study sponsor or research team.
The Affiliated Hospital of Xuzhou Medical University
Other
Clinical Significance of Circulating circRNA in Acute Ischemic Stroke (CRAST)
Acronym: CRAST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07599904
Acute Ischemic Stroke, Brain Diseases
Flint, Michigan, United States
View Trial DetailsNCT07049692
Acute Ischemic Stroke, Brain Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT07361302
Acute Ischemic Stroke, Brain Diseases
Buenos Aires, Argentina
View Trial DetailsNCT07347665
Acute Ischemic Stroke, Acute Ischemic Stroke (AIS) Related to a Distal Occlusion
Nishinomiya, Hyōgo, Japan
View Trial Details